Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research (Q37238134)

19 August 2017

Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research (English)

1 reference

19 August 2017

United States of America

1 reference

2

Muin J Khoury

1 reference

19 August 2017

Julie A Lynch

1

1 reference

19 August 2017

Ann Borzecki

3

1 reference

19 August 2017

Jerry Cromwell

4

1 reference

19 August 2017

Laura L Hayman

5

1 reference

19 August 2017

Pat Reid Ponte

6

1 reference

19 August 2017

Glenn A Miller

7

1 reference

19 August 2017

Christopher S Lathan

8

1 reference

19 August 2017

language of work or name

English

0 references

publication date

28 February 2013

1 reference

19 August 2017

1 reference

19 August 2017

15

1 reference

19 August 2017

8

1 reference

19 August 2017

630-638

1 reference

Genomics: ENCODE explained

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Translating research into practice: the role of provider-based research networks in the diffusion of an evidence-based colon cancer treatment innovation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Looking back at genomic medicine in 2011.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Personalized medicine: new genomics, old lessons

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Geographic variation in diagnosis frequency and risk of death among Medicare beneficiaries

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

New driver mutations in non-small-cell lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Non–Small Cell Lung Cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

EGFR assays in lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

The FDA critical path initiative and its influence on new drug development.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

The meaning of translational research and why it matters

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Influence of place of residence in access to specialized cancer care for African Americans

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

The effect of race on invasive staging and surgery in non-small-cell lung cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Detours on the road to personalized medicine: barriers to biomarker validation and implementation

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800006

Participation in cancer clinical trials: race-, sex-, and age-based disparities

3 September 2018

1 reference

12 December 2020

The evolving war on cancer

1 reference

12 December 2020

How can we stimulate translational research in cancer genomics beyond bench to bedside?

1 reference

12 December 2020

National Institutes of Health approaches to dissemination and implementation science: current and future directions

1 reference

12 December 2020

US FDA and personalized medicine:in vitrodiagnostic regulatory perspective

1 reference

12 December 2020

Identifiers

DOI

10.1038/GIM.2013.5

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

23448725

1 reference